Patient Access to Biomarker Testing to Provide Appropriate Therapy
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Overview
This amendment aims to improve patient access to biomarker testing within Massachusetts. It seeks to ensure that individuals can receive the necessary testing to determine the most appropriate treatment options for their medical conditions. Specifically, the amendment intends to facilitate access to these tests, potentially leading to more personalized and effective healthcare. It is attached to an appropriations bill for the fiscal year 2027.
Key provisions
- Expands access to biomarker testing for patients.
- Aims to improve the availability of these tests within the state.
- Supports the use of biomarker testing to guide treatment decisions.
- Related to appropriations for the Commonwealth's departments and activities.
Who is affected
- Patients in Massachusetts
- Healthcare providers in Massachusetts
- The Massachusetts Department of Public Health
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
3 on record
Primary sponsor
Jacob R. Oliveira
Cosponsors
Jacob R. Oliveira
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours